AUS
NZ
UK
CA
USA
IND
Healthcare
Biotech Stocks: The Milestone Map Investors Are Reading Into July
June 29, 2026 04:40 PM AEST| By SamAustralia's healthcare sector is focusing on biotechnology milestones, commercial execution, medical technology adoption and defensive earnings as investors assess operational progress before the new financial year.
Why Is ResMed (ASX:RMD) Winning Back the ASX 200 Healthcare Story?
June 29, 2026 04:03 PM AEST| By SamResMed's latest quarterly performance highlighted stronger revenue growth and improving profitability, helping refocus attention on operational execution and the long-term demand for sleep healthcare solutions.
Why Is CSL (ASX:CSL) Facing Its Toughest Healthcare Test in Years?
June 29, 2026 04:02 PM AEST| By SamCSL has returned to focus as Australia's healthcare sector experiences broad weakness driven by changing market sentiment, sector rotation and renewed attention on defensive industries.
Why Is Cochlear (ASX:COH) Facing Its Biggest Challenge Yet?
June 29, 2026 04:02 PM AEST| By SamCochlear has reset earnings expectations following weaker procedure volumes and hospital constraints, while its long-term healthcare business continues to benefit from structural demand for hearing solutions.
Neuren Pharmaceuticals (ASX:NEU) Draws Attention as Drug Pipeline Strengthens
June 29, 2026 10:06 AM AEST| By SamNeuren Pharmaceuticals continues advancing its rare disease pipeline as clinical development, licensing partnerships and regulatory progress remain key long-term business drivers.
Why Is Telix Pharmaceuticals (ASX:TLX) Standing Out This Year?
June 28, 2026 07:19 PM AEST| By SamTelix Pharmaceuticals, Lindian Resources and GemLife Communities showcase Australia's diverse growth landscape through healthcare innovation, rare earth development and specialised residential community expansion.
Why Is 4DMedical (ASX:4DX) Back in the Healthcare Spotlight?
June 28, 2026 04:03 PM AEST| By Sam4DMedical continues advancing its respiratory imaging technology through commercial expansion, healthcare innovation and growing clinical adoption across Australia and the United States.
Why ResMed (ASX:RMD) Is Rebuilding Confidence on the ASX 200?
June 26, 2026 07:57 PM AEST| By SamResMed continues demonstrating resilient healthcare demand through respiratory devices, digital health platforms and recurring revenue as market attention returns to its operating fundamentals.
Why Is CSL (ASX:CSL) Back on Healthcare Watchlists After Its Slide?
June 26, 2026 07:56 PM AEST| By SamCSL continues strengthening its healthcare business through a strategic reset, operational focus and ongoing leadership in plasma therapies as Australia's biotechnology sector attracts renewed market attention.
Why Is Cochlear (ASX:COH) Shaking the ASX 200 Healthcare Sector?
June 26, 2026 07:56 PM AEST| By SamCochlear's revised earnings outlook has renewed attention on Australia's healthcare sector as hospital constraints and softer patient demand reshape sentiment across medical technology companies.
Top ASX Healthcare Shares Back in Focus as Markets Waver
June 26, 2026 06:04 PM AEST| By SamASX healthcare stocks are attracting renewed attention as investors look toward sectors known for resilience during periods of market uncertainty.
Why Is Sigma Healthcare (ASX:SIG) Back in Focus Despite the Boots Exit?
June 26, 2026 12:08 PM AEST| By SamSigma Healthcare Ltd (ASX:SIG) remained in focus after outperforming the broader market alongside healthcare stocks.
Pro Medicus (ASX:PME) Joins Forces With EchoIQ—Could This Reshape Healthcare AI?
June 26, 2026 11:19 AM AEST| By SamPro Medicus has partnered with EchoIQ to strengthen artificial intelligence capabilities in cardiac imaging, reinforcing the growing importance of AI across healthcare diagnostics.
Pro Medicus (ASX:PME) Hunting for Its Next AI Deal? These ASX Healthcare Stocks Stand Out
June 26, 2026 11:17 AM AEST| By SamPro Medicus continues expanding its healthcare AI ecosystem, prompting attention on several ASX-listed medical technology companies operating across imaging, cardiology and diagnostic software.
4DMedical (ASX:4DX) Lands Key Approval—Can the Healthcare Rally Continue?
June 26, 2026 11:09 AM AEST| By Team Kalkine Media4DMedical has secured Australian regulatory approval for its CT:VQ imaging platform, marking an important commercial milestone as attention shifts towards adoption and reimbursement.
EIQ (ASX:EIQ): Why This Healthcare AI Partnership Has the Market Watching Closely
June 26, 2026 10:24 AM AEST| By SamEchoIQ's collaboration with Pro Medicus has strengthened attention on AI-powered healthcare innovation, highlighting the growing importance of commercial partnerships, cardiovascular diagnostics and digital transformation across Australia's technolog...
Telix Pharmaceuticals (ASX:TLX): Why Radiopharma Momentum Is Back in Focus
June 25, 2026 10:22 PM AEST| By SamRadiopharma momentum has returned to the spotlight, bringing healthcare stocks back into focus as markets place greater emphasis on execution, clinical demand, cash-flow quality and company-specific evidence.
Pro Medicus (ASX:PME) and CSL (ASX:CSL): The Healthcare Signal the Market Can’t Ignore
June 25, 2026 10:18 PM AEST| By SamDiagnostics software, recurring revenue and operational execution are becoming key drivers across healthcare stocks as the market focuses on evidence, cash flow quality and company-specific performance.
Why COH (ASX:COH) Shares Slumped After the Profit Guidance Shock?
June 25, 2026 05:36 PM AEST| By SamCochlear's sharp guidance downgrade reflects operational pressures rather than changing long-term healthcare demand, with hospital capacity, referrals and regional disruptions remaining central themes for the company's recovery.
Telix (ASX:TLX): Why Is ASX Healthcare Finding Bright Spots?
June 25, 2026 05:36 PM AEST| By SamTelix and ResMed are bright spots in Australian healthcare, showing how specialised medical markets, commercial execution and resilient demand can counter wider sector weakness and market caution.
Advertise your brand on Kalkine Media